The prognosis for men suffering from Prostate cancer has changed momentously for the better over recent years. An estimated 2,850,139 men are living with prostate cancer in the United States, according to recent studies.
They are “lucky” victims, one might say, because of breakthroughs that may potentially allow doctors to stop the disease in its tracks, according to the Association of Mature American Citizen.
One treatment, Stereotactic Body Radiation Therapy (SBRT), for example, is reported to have a nearly 99% cure rate. Dr. Raquibul Hannan, Assistant Professor of Radiation Oncology at the University of Texas Southwestern Medical Center in Dallas, led a study that revealed just how effective this new means of pinpointing radiation delivery is.
“The high cure rate is striking when compared to the reported five-year cure rates from other approaches like surgery or conventional radiation, which range between 80 to 90 percent, while the side effects of this treatment are comparable to other types of treatment.”